Morgan Stanley
VTAK icon

Morgan Stanley’s Catheter Precision VTAK Stock Holding History

Morgan Stanley’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42
Closed -$47.5K – 7830
2022
Q4 		$47.5K Buy
+42
New +$34.8K ﹤0.01% 6315
2022
Q3 		– Hold
0
– – – 7889
2021
Q4 		– Hold
0
– -$9K – 8120
2021
Q3 		– Hold
0
– – – 7372
2021
Q2 		– Sell
-2
Closed -$83.1K – 7542
2021
Q1 		$71K Buy
+2
New +$131K ﹤0.01% 6188

Other funds holding VTAK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Morgan Stanley's VTAK Position: Q1 2023 in Review

Morgan Stanley sold out of Catheter Precision (VTAK) in Q1 2023, closing a stake of 42 shares — an estimated $47.5K sold.

Morgan Stanley first reported a position in VTAK in Q1 2021 and held it in 2 quarters. The position peaked at $71K in Q1 2021. 8 funds tracked by Wall St. Rank hold VTAK as of Q1 2023.

  • Morgan Stanley reported no remaining Catheter Precision position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 42 Catheter Precision shares in Q1 2023, an estimated $47.5K.
  • Morgan Stanley first reported a position in Catheter Precision in Q1 2021 and held it in 2 quarters.
  • Morgan Stanley's Catheter Precision position peaked at $71K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.